Literature DB >> 7733910

Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption.

T A Hentunen1, P T Lakkakorpi, J Tuukkanen, P P Lehenkari, T K Sampath, H K Väänänen.   

Abstract

Recombinant human OP-1 stimulated the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells (MNCs) significantly and in a dose-dependent manner in rat bone marrow cell culture. Newly formed MNCs either induced by hOP-1 alone or with 1,25(OH)2D3 were also positive for vitronectin receptor and carbonic anhydrase II. Moreover, OP-1 markedly increased the capacity of 1,25(OH)2D3 to induce osteoclast-like cell formation and bone resorption in bone marrow cultures. 25 pg/ml of calcitonin significantly inhibited both OP-1- and vitamin D3-induced TRAP-positive MNC-formation in marrow cultures, indicating that in both cases the MNC formation was calcitonin sensitive. OP-1 at 5-100 ng/ml did not have any significant effect on bone resorption as studied by pit formation assay. These studies that OP-1 in concert with 1,25(OH)2D3 could have an important role in bone remodeling by exhibiting its effects not only on osteoblast growth and differentiation but also on the recruitment of osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733910     DOI: 10.1006/bbrc.1995.1521

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

Review 2.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

3.  BMPs in periprosthetic tissues around aseptically loosened total hip implants.

Authors:  Ville Waris; Eero Waris; Tarvo Sillat; Yrjö T Konttinen
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

4.  Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.

Authors:  N Mathavan; M Tägil; H Isaksson
Journal:  Osteoporos Int       Date:  2016-11-07       Impact factor: 4.507

Review 5.  Bone morphogenetic proteins: Their role in regulating osteoclast differentiation.

Authors:  Raphael Huntley; Eric Jensen; Rajaram Gopalakrishnan; Kim C Mansky
Journal:  Bone Rep       Date:  2019-05-05

Review 6.  The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.

Authors:  Tatjana Bordukalo-Nikšić; Vera Kufner; Slobodan Vukičević
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

7.  Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1.

Authors:  Thomas Maurer; Gerald Zimmermann; Susanne Maurer; Sabine Stegmaier; Christof Wagner; G Maria Hänsch
Journal:  Mediators Inflamm       Date:  2012-10-24       Impact factor: 4.711

Review 8.  The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective.

Authors:  Franziska Lademann; Lorenz C Hofbauer; Martina Rauner
Journal:  Front Cell Dev Biol       Date:  2020-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.